Raspberry seeds extract selectively inhibits the growth of human lung cancer cells in vitro

Nat Prod Res. 2021 Jul;35(13):2253-2256. doi: 10.1080/14786419.2019.1666391. Epub 2019 Sep 17.

Abstract

This study was focused on in vitro cytotoxicity screening of the raspberry seeds methanol extract towards a number of cancer cell lines of human origin. The tested extract at the preferred concentrations (IC50 <30 µg/mL) inhibited only the growth of the lung cancer A-549 cells (IC50 = 14.07 ± 0.96 µg/mL). At the same time, it was practically inactive (IC50 >300 µg/mL) and non-mutagenic towards normal MRC-5 lung cells. Finally, the extract potently scavenged both OH· (IC50 = 20.11 ± 1.77 µg/mL) and O2-· (IC50 = 47.23 ± 3.82 µg/mL), the free radicals of proved relevance for cancer pathophysiology. Though seeds were enriched with phenolic compounds (TPC = 5.21 ± 0.07 mg GAE/g), anthocyanins were present in traces only (TAC = 0.07 ± 0.003 mg cyn-3-glu/g), while flavonoids were not detected at all. This is the first report on anti-lung cancer potential of the seeds of any soft fruit.

Keywords: A-549 cells; MRC-5 cells; ROS; Soft fruit; comet assay; extract; phenolics.

MeSH terms

  • Antioxidants / pharmacology
  • Cell Line, Tumor
  • Humans
  • Inhibitory Concentration 50
  • Lung Neoplasms / pathology*
  • Plant Extracts / pharmacology*
  • Rubus / chemistry*
  • Seeds / chemistry*

Substances

  • Antioxidants
  • Plant Extracts